Cargando…

Socioeconomic gradient in COVID-19 vaccination: evidence from Israel

BACKGROUND: Low socioeconomic status (SES) groups have been disproportionately affected by the COVID-19 pandemic. We aimed to examine COVID-19 vaccination rate by neighborhood SES and ethnicity in Israel, a country which has achieved high vaccination rates. METHODS: Data on vaccinations were obtaine...

Descripción completa

Detalles Bibliográficos
Autores principales: Saban, Mor, Myers, Vicki, Ben-Shetrit, Shani, Wilf-Miron, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574141/
https://www.ncbi.nlm.nih.gov/pubmed/34749718
http://dx.doi.org/10.1186/s12939-021-01566-4
_version_ 1784595559636533248
author Saban, Mor
Myers, Vicki
Ben-Shetrit, Shani
Wilf-Miron, Rachel
author_facet Saban, Mor
Myers, Vicki
Ben-Shetrit, Shani
Wilf-Miron, Rachel
author_sort Saban, Mor
collection PubMed
description BACKGROUND: Low socioeconomic status (SES) groups have been disproportionately affected by the COVID-19 pandemic. We aimed to examine COVID-19 vaccination rate by neighborhood SES and ethnicity in Israel, a country which has achieved high vaccination rates. METHODS: Data on vaccinations were obtained from the Israeli Ministry of Health’s open COVID-19 database, for December 20, 2020 to August 31, 2021. Correlation between vaccination rate and neighborhood SES was analyzed. Difference in vaccination rate between the first and second vaccine dose was analyzed by neighborhood SES and ethnicity. FINDINGS: A clear socioeconomic gradient was demonstrated, with higher vaccination rates in the higher SES categories (first dose: r = 0.66; second dose: r = 0.74; third dose: r = 0.92). Vaccination uptake was lower in the lower SES groups and in the Arab population, with the largest difference in uptake between Jewish and Arab localities for people younger than 60, and with the gap widening between first and third doses. CONCLUSIONS: Low SES groups and the Arab ethnic minority demonstrated disparities in vaccine uptake, which were greater for the second and third, compared with the first vaccine dose. Strategies to address vaccination inequity will need to identify barriers, provide targeted information, and include trust-building in disadvantaged communities.
format Online
Article
Text
id pubmed-8574141
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85741412021-11-08 Socioeconomic gradient in COVID-19 vaccination: evidence from Israel Saban, Mor Myers, Vicki Ben-Shetrit, Shani Wilf-Miron, Rachel Int J Equity Health Research BACKGROUND: Low socioeconomic status (SES) groups have been disproportionately affected by the COVID-19 pandemic. We aimed to examine COVID-19 vaccination rate by neighborhood SES and ethnicity in Israel, a country which has achieved high vaccination rates. METHODS: Data on vaccinations were obtained from the Israeli Ministry of Health’s open COVID-19 database, for December 20, 2020 to August 31, 2021. Correlation between vaccination rate and neighborhood SES was analyzed. Difference in vaccination rate between the first and second vaccine dose was analyzed by neighborhood SES and ethnicity. FINDINGS: A clear socioeconomic gradient was demonstrated, with higher vaccination rates in the higher SES categories (first dose: r = 0.66; second dose: r = 0.74; third dose: r = 0.92). Vaccination uptake was lower in the lower SES groups and in the Arab population, with the largest difference in uptake between Jewish and Arab localities for people younger than 60, and with the gap widening between first and third doses. CONCLUSIONS: Low SES groups and the Arab ethnic minority demonstrated disparities in vaccine uptake, which were greater for the second and third, compared with the first vaccine dose. Strategies to address vaccination inequity will need to identify barriers, provide targeted information, and include trust-building in disadvantaged communities. BioMed Central 2021-11-08 /pmc/articles/PMC8574141/ /pubmed/34749718 http://dx.doi.org/10.1186/s12939-021-01566-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Saban, Mor
Myers, Vicki
Ben-Shetrit, Shani
Wilf-Miron, Rachel
Socioeconomic gradient in COVID-19 vaccination: evidence from Israel
title Socioeconomic gradient in COVID-19 vaccination: evidence from Israel
title_full Socioeconomic gradient in COVID-19 vaccination: evidence from Israel
title_fullStr Socioeconomic gradient in COVID-19 vaccination: evidence from Israel
title_full_unstemmed Socioeconomic gradient in COVID-19 vaccination: evidence from Israel
title_short Socioeconomic gradient in COVID-19 vaccination: evidence from Israel
title_sort socioeconomic gradient in covid-19 vaccination: evidence from israel
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574141/
https://www.ncbi.nlm.nih.gov/pubmed/34749718
http://dx.doi.org/10.1186/s12939-021-01566-4
work_keys_str_mv AT sabanmor socioeconomicgradientincovid19vaccinationevidencefromisrael
AT myersvicki socioeconomicgradientincovid19vaccinationevidencefromisrael
AT benshetritshani socioeconomicgradientincovid19vaccinationevidencefromisrael
AT wilfmironrachel socioeconomicgradientincovid19vaccinationevidencefromisrael